Made possible with support from Genentech BioOncology
Metastatic breast cancer occurs when breast cancer cells are transported to other parts of the body via the circulatory and/or lymphatic systems and begin to multiply there. There are important tumor characteristics that determine the likely prognosis and best management approach, including whether the cancer cell has estrogen and/or progesterone hormone receptors.
After this program, you will be able to:
|
William Gradishar, M.D., F.A.C.P.
Medical Oncologist, Northwestern Memorial Hospital
Dr. William Gradishar is an oncologist on the medical staff at Northwestern Memorial Hospital, director of Breast Medical Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and professor of Medicine at Northwestern University’s Feinberg School of Medicine. Dr. Gradishar specializes in hematology/oncology and breast cancer. He received his medical degree from the University of Illinois College...
more >
|
|
|
|
Lillie Shockney, R.N., B.S., M.A.S., CBCN, CBPN-C
Administrative Director, Johns Hopkins Avon Foundation Breast Center, Johns Hopkins
Lillie Shockney has been the administrative director of the Johns Hopkins Avon Foundation Breast Center since 1997. A two-time breast cancer survivor, Lillie has worked tirelessly to improve the care of breast cancer patients around the world. She is a registered nurse with a Bachelor of Science degree in health care administration from Saint Joseph's College and a Masters in...
more >
|
|
|

